Thanks again for posting it Prestonian.
Since we may see some interest from this media coverage, Next Biotech has some good articles on DXB & whilst they are older editorials & therefore do not include current & up to date $ figures for Dimerix, I think these articles give a pretty good snapshot of where we have been & where we are going.
http://www.nextbiotech.com.au/company/dxb/
New drug "expected to hit the market within 2 years", page-16
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.015(4.05%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.3¢ | $442.1K | 1.222M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 256045 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 15870 | 3 |
View Market Depth
| Last trade - 13.11pm 05/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |